Mounjaro 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM7X4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,410
Award facts
- Contract value 100% obligated
- $30,410.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,410.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injections on December 23, 2025, with an ultimate completion date of December 24, 2025. This competitively awarded contract, which carries no set-aside designation, represents a small delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be fulfilled from the vendor's corporate headquarters location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes, reflecting the pharmaceutical distributor's ongoing role in supplying critical medications to federal healthcare systems.
AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 prime IDC with DLA Troop Support Medical through December 2026, designated SPE2DX, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. This delivery order exemplifies the company's extensive federal procurement portfolio, which encompasses brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains. As a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, AmerisourceBergen maintains significant capacity to fulfill federal medical supply requirements through competitive procurement mechanisms.
Quick answers
Who was awarded contract SPE2DR26FM7X4?
SPE2DR26FM7X4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26FM7X4 worth?
The government has obligated $30,410 on SPE2DR26FM7X4.
Is contract SPE2DR26FM7X4 an order under another contract?
Yes. SPE2DR26FM7X4 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM7X4 competed?
The extent of competition for SPE2DR26FM7X4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award